Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Fractional Radiofrequency for the Treatment of Moderate to Severe Acne Vulgaris

NCT06315166 is registered in ClinicalTrials.gov with Pollogen as lead sponsor.

NCT NCT06315166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06315166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Fractional Radiofrequency for the Treatment of Moderate to Severe Acne Vulgaris
Lead sponsor
Pollogen
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 23, 2024
Completion date
December 31, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe acne vulgaris